Literature DB >> 8999930

Heparanases produce distinct populations of heparan sulfate glycosaminoglycans in Chinese hamster ovary cells.

K J Bame1, K Robson.   

Abstract

Once internalized, cell-associated heparan sulfate proteoglycans are degraded to short glycosaminoglycans by the action of endoglycosidases or heparanases. We have begun to address the question of how many heparanases are responsible for this process by analyzing short heparan sulfate chains produced in vivo by Chinese hamster ovary (CHO) cell heparanases. Short heparan sulfate chains were purified from CHO cells and labeled at the reducing end with [3H]NaBH4. Hydrolysis of the chains to monosaccharides and analysis of the 3H-sugar alcohols indicate that heparanase activities in CHO cells are endo-beta-glucuronidases. The modification state of the heparanase-derived glycosaminoglycans was examined by treating the [3H]heparan sulfate chains with nitrous acid or bacterial heparin lyases, which cut the chain at specific sequences, and analyzing the products by P2 gel filtration chromatography. Two populations of short chains were identified that differ in the extent of modification on the nonreducing side of the heparanase cleavage site. One class of chains is unmodified for at least 9 residues from the reducing end, while the other group has a modified domain within 3-7 residues from the heparanase cleavage site. Our results suggest a model of heparanase action where the enzymes recognize differences in sulfate content between modified and unmodified regions and bind to sites that encompass both domains. The enzymes then cleave the glycosaminoglycan at junctions between the modified and unmodified sequences to produce the different populations of short heparan sulfate chains.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8999930

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Characterization of a novel intracellular heparanase that has a FERM domain.

Authors:  Karen J Bame; Indumati Venkatesan; Jean Dehdashti; Jeffrey McFarlane; Rebecca Burfeind
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

2.  Evidence that platelet and tumour heparanases are similar enzymes.

Authors:  C Freeman; A M Browne; C R Parish
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

3.  Basic fibroblast growth factor does not prevent heparan sulphate proteoglycan catabolism in intact cells, but it alters the distribution of the glycosaminoglycan degradation products.

Authors:  S Tumova; B A Hatch; D J Law; K J Bame
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

4.  Human platelet heparanase: purification, characterization and catalytic activity.

Authors:  C Freeman; C R Parish
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

5.  Partial purification of heparanase activities in Chinese hamster ovary cells: evidence for multiple intracellular heparanases.

Authors:  K J Bame; A Hassall; C Sanderson; I Venkatesan; C Sun
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

6.  Distribution of Heparan Sulfate Oligosaccharides in Murine Mucopolysaccharidosis Type IIIA.

Authors:  Kerryn Mason; Peter Meikle; John Hopwood; Maria Fuller
Journal:  Metabolites       Date:  2014-12-11

7.  An integrated approach using orthogonal analytical techniques to characterize heparan sulfate structure.

Authors:  Daniela Beccati; Miroslaw Lech; Jennifer Ozug; Nur Sibel Gunay; Jing Wang; Elaine Y Sun; Joël R Pradines; Victor Farutin; Zachary Shriver; Ganesh V Kaundinya; Ishan Capila
Journal:  Glycoconj J       Date:  2016-10-22       Impact factor: 2.916

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.